During the past decade, Capio Citykliniken Hjartmottagning conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Capio Citykliniken Hjartmottagning" are "Cardiovascular Disease" (1 trials) and "Hyperlipidemia" (1 trials). Many other conditions were trialed in "Capio Citykliniken Hjartmottagning" in a lesser frequency.

Most popular intervention types in "Capio Citykliniken Hjartmottagning" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Bococizumab (PF-04950615; RN316)" (1 trials) and "bococizumab (PF-04950615)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Capio Citykliniken Hjartmottagning" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Capio Citykliniken Hjartmottagning". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Capio Citykliniken Hjartmottagning, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Capio Citykliniken Hjartmottagning, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Capio Citykliniken Hjartmottagning has several departments that took part in Clinical trials: "Capio Artro Clinic AB" - 4 trials